Distraction-Based Interventions During Implanted Venous Port Catheter Needle Entry: Virtual Reality Application

NCT ID: NCT06551753

Last Updated: 2024-08-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-15

Study Completion Date

2024-07-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a randomized controlled experimental study planned to examine the effect of virtual reality application during implanted venous port catheter needle insertion on patient satisfaction, comfort level and time perception in cancer patients. Distraction-based interventions used in symptom management of cancer patients are simple, effective and cost-effective. Distraction applications such as virtual reality glasses, listening to music, painting and daydreaming aim to focus attention on another stimulus. Virtual reality application uses human-machine interfaces to focus the patient on a world other than their current environment with a three-dimensional virtual video, changing their perception of space and time. It has been shown that virtual reality applications reduce pain and anxiety, increase patient satisfaction, provide relief, and positively affect vital parameters during procedural procedures such as bone marrow aspiration, fine needle aspiration breast biopsy, colonoscopy, and transrectal prostate biopsy in cancer patients receiving chemotherapy.

Virtual reality is a new technique developed thanks to the advancement of computer technology and started to be used in the field of health as a cognitive-behavioral method to relieve pain and relax the patient. This method uses human-machine interfaces to give people the feeling of being in an interactive environment with virtual video in the forest, ocean or space. Virtual reality glasses are an application that is used to isolate the patient from his/her environment and includes a distraction method that allows the patient to focus on another world in three dimensions. It is usually applied with glasses or headgear. In addition, the patient is prevented from perceiving the surrounding sounds by wearing headphones. The most important feature that distinguishes virtual reality from other technological products such as television and video games is that it gives users the feeling of being in a different place. The use of virtual reality glasses provides a positive environment for patients and provides a calming experience by changing their perception of time.Virtual reality applications, a new technology, can make a positive difference in cancer care and increase the comfort and satisfaction levels of cancer patients. This innovative method can be used as a complementary nursing approach in addition to standard care during implantable venous port catheter needle intervention. The widespread use of virtual reality applications in cancer care contributes to qualified nursing care. This study will be presented as an innovative method showing that virtual reality technologies can be incorporated into nursing practices.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a randomized controlled experimental study planned to examine the effect of virtual reality application during implanted venous port catheter needle insertion on patient satisfaction, comfort level and time perception in cancer patients. Distraction-based interventions used in symptom management of cancer patients are simple, effective and cost-effective. Distraction applications such as virtual reality glasses, listening to music, painting and daydreaming aim to focus attention on another stimulus. Virtual reality application uses human-machine interfaces to focus the patient on a world other than their current environment with a three-dimensional virtual video, changing their perception of space and time. It has been shown that virtual reality applications reduce pain and anxiety, increase patient satisfaction, provide relief, and positively affect vital parameters during procedural procedures such as bone marrow aspiration, fine needle aspiration breast biopsy, colonoscopy, and transrectal prostate biopsy in cancer patients receiving chemotherapy.

Virtual reality is a new technique developed thanks to the advancement of computer technology and started to be used in the field of health as a cognitive-behavioral method to relieve pain and relax the patient. This method uses human-machine interfaces to give people the feeling of being in an interactive environment with virtual video in the forest, ocean or space. Virtual reality glasses are an application that is used to isolate the patient from his/her environment and includes a distraction method that allows the patient to focus on another world in three dimensions. It is usually applied with glasses or headgear. In addition, the patient is prevented from perceiving the surrounding sounds by wearing headphones. The most important feature that distinguishes virtual reality from other technological products such as television and video games is that it gives users the feeling of being in a different place. The use of virtual reality glasses provides a positive environment for patients and provides a calming experience by changing their perception of time. Virtual reality applications, a new technology, can make a positive difference in cancer care and increase the comfort and satisfaction levels of cancer patients. This innovative method can be used as a complementary nursing approach in addition to standard care during implantable venous port catheter needle intervention. The widespread use of virtual reality applications in cancer care contributes to qualified nursing care. This study will be presented as an innovative method showing that virtual reality technologies can be incorporated into nursing practices.

Research Inclusion Criteria:

* Those between the ages of 18-65
* Those receiving active chemotherapy
* Those who volunteer to participate in the research
* Having an implantable venous port catheter
* Those who will use virtual reality glasses for the first time

Exclusion Criteria from the Research:

* Presence of metastasis
* Those receiving anxiolytic drug treatment
* Those receiving antidepressant medication
* People with communication, hearing and vision problems
* Having any psychiatric disorder
* Those who used any analgesic medication at least 8 hours before
* Those with migraine, vertigo, active nausea-vomiting, headache, dizziness problems Patient introductory information form, satisfaction status evaluation scale, general comfort scale-short form and time perception evaluation form during the procedure will be used as data collection tools.

Data Collection Phase:

Before starting the research, written informed consent will be obtained from cancer patients who agree to participate in the study and meet the inclusion criteria, by explaining the purpose and rationale of the research. In the research, simple randomization method will be used to determine the sample number of intervention and control groups. They will be assigned to the control (n = 35) and intervention (n = 35) groups by simple randomization method from a simple random numbers table prepared before the study. Using the simple random numbers table, patients assigned to the intervention group will be shown a three-minute video, determined by the patient's choice, from video scenes containing nature images with sound shot at a 360-degree angle recorded on YouTube, through a virtual reality headset, throughout the procedure. The application will begin as soon as the patient is positioned, just before the procedure begins, and will continue after the procedure is completed, allowing them to experience a three-dimensional virtual reality application that lasts approximately 3 minutes. Data will be collected by face-to-face interview with patients before and after the procedure. Patient introductory information form, satisfaction status evaluation scale, general comfort scale-short form and time perception evaluation form during the procedure will be used as data collection tools. The study will be carried out in the same environment with a single nurse, the same measurement tools will be used, and procedures will be applied to both the control and experimental groups by the same nurse.

Evaluation of Data:

Descriptive and comparative statistics, correlation and regression analyzes will be used to evaluate the data obtained from the study. SPSS 25.0 Package Program will be used to analyze the data. Categorical measurements will be presented as numbers and percentages, and numerical measurements will be presented as mean and standard deviation, median, minimum and maximum values. Chi-Square Test statistics will be used to compare categorical measurements between groups. Whether numerical measurements provide normal distribution will be evaluated with the Kolmogrov-Smirnov Test. In independent groups, t test will be used, and if the assumptions are not met, Mann Whitney U test will be used. Spearman correlation analyzes will be applied for correlation analyzes between data. Statistical significance level will be accepted as p\<0.05. The research results will be evaluated and presented in the light of the literature.

CENTER/CENTERS WHERE THE RESEARCH WILL BE CONDUCTED; Bursa Uludağ University Faculty of Medicine Hospital Medical Oncology Polyclinic

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

a randomized controlled experimental study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Given the nature of the intervention, the investigator and patients were not blinded to the intervention. Since the patients in the intervention group were fitted with virtual reality glasses, blinding could not be performed due to the nature of the study. However, patients were blind to randomization until administration began. After the patient was pre-tested, he was informed by the researcher that he was in the intervention or control group. The investigator was also blind to randomization. Patients were assigned to intervention and control groups by an independent selection from a simple bag of random numbers prepared for randomization. Analysis of the study data was also performed by an independent statistician who was unaware of the intervention and control groups. In this study, blinding was ensured in the implementation of randomization and analysis and reporting of data.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

virtual reality app

virtual reality app

Group Type EXPERIMENTAL

virtual reality app

Intervention Type OTHER

virtual reality app

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

virtual reality app

virtual reality app

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those between the ages of 18-65
* Those receiving active chemotherapy
* Those who volunteer to participate in the research
* Having an implantable venous port catheter
* Those who will use virtual reality glasses for the first time

Exclusion Criteria

* Presence of metastasis
* Those receiving anxiolytic drug treatment
* Those receiving antidepressant medication
* People with communication, hearing and vision problems
* Having any psychiatric disorder
* Those who used any analgesic medication at least 8 hours before
* Those with migraine, vertigo, active nausea-vomiting, headache, dizziness problems
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uludag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Esra ibek

Oncology Clinic Nurse

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Derya Çınar, Doç. Dr.

Role: STUDY_DIRECTOR

Izmir Bakircay University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

İzmir Bakırçay University

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Chen YB, Bao HS, Hu TT, He Z, Wen B, Liu FT, Su FX, Deng HR, Wu JN. Comparison of comfort and complications of Implantable Venous Access Port (IVAP) with ultrasound guided Internal Jugular Vein (IJV) and Axillary Vein/Subclavian Vein (AxV/SCV) puncture in breast cancer patients: a randomized controlled study. BMC Cancer. 2022 Mar 5;22(1):248. doi: 10.1186/s12885-022-09228-6.

Reference Type BACKGROUND
PMID: 35248019 (View on PubMed)

Brunetti GA, Tendas A, Meloni E, Mancini D, Maggiore P, Scaramucci L, Giovannini M, Niscola P, Cartoni C, Alimena G. Pain and anxiety associated with bone marrow aspiration and biopsy: a prospective study on 152 Italian patients with hematological malignancies. Ann Hematol. 2011 Oct;90(10):1233-5. doi: 10.1007/s00277-011-1166-7. Epub 2011 Feb 2. No abstract available.

Reference Type BACKGROUND
PMID: 21287348 (View on PubMed)

Taxbro K, Hammarskjold F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Br J Anaesth. 2019 Jun;122(6):734-741. doi: 10.1016/j.bja.2019.01.038. Epub 2019 Apr 17.

Reference Type BACKGROUND
PMID: 31005243 (View on PubMed)

Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol. 2019 Feb;54(2):407-419. doi: 10.3892/ijo.2018.4661. Epub 2018 Dec 10.

Reference Type BACKGROUND
PMID: 30570109 (View on PubMed)

Gupta A, Scott K, Dukewich M. Innovative Technology Using Virtual Reality in the Treatment of Pain: Does It Reduce Pain via Distraction, or Is There More to It? Pain Med. 2018 Jan 1;19(1):151-159. doi: 10.1093/pm/pnx109.

Reference Type BACKGROUND
PMID: 29025113 (View on PubMed)

Hundert AS, Birnie KA, Abla O, Positano K, Cassiani C, Lloyd S, Tiessen PH, Lalloo C, Jibb LA, Stinson J. A Pilot Randomized Controlled Trial of Virtual Reality Distraction to Reduce Procedural Pain During Subcutaneous Port Access in Children and Adolescents With Cancer. Clin J Pain. 2021 Dec 30;38(3):189-196. doi: 10.1097/AJP.0000000000001017.

Reference Type BACKGROUND
PMID: 34974512 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UÜEİ001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.